Lifecore Biomedical (LDE) Financial Statements
Lifecore Biomedical Financial Overview
Lifecore Biomedical's market cap is currently $217.22M. The company's EPS TTM is $-0.81; its P/E ratio is -5.82; Lifecore Biomedical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | May 25 | May 24 | Aug 23 | May 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 129.46M | $ 128.87M | $ 128.26M | $ 103.27M | $ 111.27M |
| Gross Profit | $ 40.61M | $ 40.30M | $ 41.85M | $ 27.98M | $ 39.07M |
| Operating Income | $ -1.26M | $ -17.25M | $ -8.84M | $ -21.80M | $ -11.79M |
| EBITDA | $ 8.24M | $ -8.81M | $ 35.56M | $ -33.17M | $ 12.84M |
| Net Income | $ -30.79M | $ -38.72M | $ 12.01M | $ -99.56M | $ -116.72M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 17.47M | $ 8.27M | $ 8.46M | $ 19.09M | $ 991.00K |
| Total Assets | $ 232.18M | $ 239.34M | $ 253.96M | $ 253.54M | $ 274.70M |
| Total Debt | $ 142.61M | $ 130.82M | $ 133.57M | $ 112.62M | $ 247.78M |
| Net Debt | $ 125.14M | $ 122.56M | $ 125.11M | $ 93.53M | $ 246.79M |
| Total Liabilities | $ 246.38M | $ 238.01M | $ 242.65M | $ 257.77M | $ 186.88M |
| Stockholders' Equity | $ -14.20M | $ 1.34M | $ 11.31M | $ -4.23M | $ 87.82M |
| Cash Flow | |||||
| Free Cash Flow | $ 6.23M | $ -13.62M | $ -18.14M | $ -38.92M | $ -52.53M |
| Operating Cash Flow | $ 12.57M | $ -206.00K | $ 257.00K | $ -17.44M | $ -22.59M |
| Investing Cash Flow | $ -1.63M | $ -6.42M | $ -18.39M | $ -4.81M | $ 79.96M |
| Financing Cash Flow | $ -1.11M | $ 6.42M | $ 7.51M | $ 39.70M | $ -57.02M |
Currency in USD
